Systemic Lupus Erythematosus (SLE): Prevalence, Pathophysiology and Prognosis

Syuichi Koarada, MD (Editor)
The Division of Rheumatology Saga University, Japan

Series: Immunology and Immune System Disorders
BISAC: MED083000



Volume 10

Issue 1

Volume 2

Volume 3

Special issue: Resilience in breaking the cycle of children’s environmental health disparities
Edited by I Leslie Rubin, Robert J Geller, Abby Mutic, Benjamin A Gitterman, Nathan Mutic, Wayne Garfinkel, Claire D Coles, Kurt Martinuzzi, and Joav Merrick


Digitally watermarked, DRM-free.
Immediate eBook download after purchase.

Product price
Additional options total:
Order total:


Browse Wishlist
Browse Wishlist


Systemic lupus erythematosus (SLE) is one of the prototypical systemic autoimmune diseases characterized by inflammation, immune complex deposition, and vasculitis.@Patients with SLE show various symptoms and clinical images, both constitutional and specific organ symptoms. They include the skin, joints, muscles, kidneys, lungs, nervous system, and blood vessels. Although the etiology of the disease is still unclear, genetic, hormonal, immunologic abnormalities and environmental factors complicatedly play important roles in the pathophysiology in SLE. It is evident that multiple genes show genetic susceptibility to SLE. Environmental factors of SLE and immunologic abnormalities, especially the production of a number of auto-antibody, are important features of the disease.

In this book, we present recent knowledge about the prevalence, pathophysiology and prognosis of SLE. The book includes various interesting chapters: Chapter One – an illustrated overview of the prevalence and clinical symptoms of systemic lupus erythematosus; Chapter Two – the pathophysiology of systemic lupus erythematosus; Chapter Three – MBL and MBL genotypes in SLE; Chapter Four – novel biological activities of autoantibodies as the potential markers of systematic lupus erythematosus; Chapter Five – cytokines in systemic lupus erythematosus (sle) with clinical aspects and prognostics; Chapter Six – prognosis in systemic lupus erythematosus; and Chapter Seven – autoantibody-producing RP105-negative B cells in humans and a murine model of lupus erythematosus. (Imprint: Nova Biomedical )

Chapter 1. Illustrated Overview of the Prevalence and Clinical Symptoms of Systemic Lupus Erythematosus
(Syuichi Koarada, Yuri Sadanaga, Natsumi Nagao, Satoko Tashiro, Rie Suematsu, Akihide Ohta and Yoshifumi Tada, Division of Rheumatology, Department of Internal Medicine, Saga University School of Medicine, Saga, Japan)

Chapter 2. The Pathophysiology of Systemic Lupus Erythematosus
(Mariana Postal and Simone Appenzeller, State University of Campinas, SP, Brazil and others)

Chapter 3. MBL and MBL Genotypes in SLE
(Zornitsa Kamenarska, Maria Hristova and Lyubomir Dourmishev, Molecular Medicine Centre, Medical University-Sofia, Sofia, Bulgaria, and others)

Chapter 4. Novel Biological Activities of Autoantibodies as the Potential Markers of Systemic Lupus Erythematosus
(Yuriy Kit, Iryna Magorivska, Valentyna Chopyak, Yaroslav Tolstiak, Rostyslav Bilyy and Rostyslav Stoika, Institute of Cell Biology, National Academy of Sciences of Ukraine, Lviv, Ukraine, and others)

Chapter 5. Cytokines in Systemic Lupus Erythematosus (SLE): Clinical Aspects and Prognostics
(P.R.E. Souza, J. De Azevêdo Silva, N.M.J. Asano and P. Sandrin-Garcia, Laboratory of Genetic Biochemistry, University Federal of Pernambuco, Brazil)

Chapter 6. Prognosis in Systemic Lupus Erythematosus
(Nailú Angélica Sinicato and Simone Appenzeller, State University of Campinas, Brazil)

Chapter 7. Autoantibody-Producing RP105-Negative B Cells in Humans and a Murine Model of Lupus Erythematosus
(Syuichi Koarada and Yoshifumi Tada, Division of Rheumatology, Department of Internal Medicine, Saga University School of Medicine, Saga, Japan)


You have not viewed any product yet.